Completed
GSK2190915A - Bioavailability Study
NCT02224521
- Conditions
- Asthma, Bronchial Diseases, Chronic Disease, +11 more
- Locations
-
- GSK Investigational Site London, United Kingdom
Clinical trial condition
Respiratory Hypersensitivity
Explore clinical trials studying Respiratory Hypersensitivity. Study availability and eligibility vary by location and protocol.
4,459 public trials
325 recruiting studies
Respiratory Hypersensitivity trial results
NCT02953041
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Asthma Research Lab, University of Saskatchewan Saskatoon, Saskatchewan, Canada
NCT01213849
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site London, United Kingdom
NCT00777764
- Conditions
- Asthma, Bronchial Diseases, Healthy, +7 more
- Locations
-
Not specified
NCT01160003
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site Berlin, Germany
NCT00096954
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
Not specified
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site Groningen, Netherlands
NCT01299558
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site Randwick, New South Wales, Australia
NCT01772368
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Teva Investigational Site 10453 Denver, Colorado, United States
- Teva Investigational Site 10452 North Dartmouth, Massachusetts, United States
- Teva Investigational Site 10455 St Louis, Missouri, United States
- Teva Investigational Site 10454 Skillman, New Jersey, United States
NCT01485445
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site Berlin, Germany